Filtered By:
Condition: Hemorrhagic Stroke

This page shows you your search results in order of relevance. This is page number 14.

Order by Relevance | Date

Total 19785 results found since Jan 2013.

Caffeine-Containing Medicines Increase the Risk of Hemorrhagic Stroke Clinical Sciences
Conclusions— These results suggest that use of CCMs is associated with increased risk of HS, both subarachnoid hemorrhage and intracerebral hemorrhage.
Source: Stroke - July 22, 2013 Category: Neurology Authors: Lee, S.-M., Choi, N.-K., Lee, B.-C., Cho, K.-H., Yoon, B.-W., Park, B.-J. Tags: Behavioral Changes and Stroke, Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage, Intracerebral Hemorrhage, Risk Factors for Stroke, Epidemiology Clinical Sciences Source Type: research

Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke-Enhanced Regimen Stroke Trial Major Clinical Trial
Conclusions— The combined regimen of intravenous rt-PA and eptifibatide studied in this trial was safe and provides evidence that a phase III trial is warranted to determine efficacy of the regimen. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00894803.
Source: Stroke - August 26, 2013 Category: Neurology Authors: Pancioli, A. M., Adeoye, O., Schmit, P. A., Khoury, J., Levine, S. R., Tomsick, T. A., Sucharew, H., Brooks, C. E., Crocco, T. J., Gutmann, L., Hemmen, T. M., Kasner, S. E., Kleindorfer, D., Knight, W. A., Martini, S., McKinney, J. S., Meurer, W. J., Meye Tags: Emergency treatment of Stroke, Antiplatelets, Thrombolysis Major Clinical Trial Source Type: research

The iScore Predicts Efficacy and Risk of Bleeding in the National Institute of Neurological Disorders and Stroke Tissue Plasminogen Activator Stroke Trial
The iScore is a validated tool to estimate outcomes after an acute ischemic stroke. A previous study showed the iScore can predict clinical response and risk of intracerebral hemorrhage (ICH) after administration of tissue plasminogen activator (tPA). We applied the iScore (www.sorcan.ca/iscore) to participants in the National Institute of Neurological Disorders and Stroke tPA stroke trials to evaluate its ability to estimate clinical response and risk of ICH after thrombolysis. Based on results from our previous study, patients were stratified a priori into iScore
Source: Journal of Stroke and Cerebrovascular Diseases - October 26, 2012 Category: Neurology Authors: Gustavo Saposnik, Andrew Demchuk, Jack V. Tu, S. Claiborne Johnston, Stroke Outcomes Research Canada (SORCan) Working Group Tags: Original Articles Source Type: research

Impact of Stroke Care Unit on Patient Outcomes in a Community Hospital Clinical Sciences
Conclusions— Establishing a SCU in a community hospital not only increases the survival of stroke patients, but also the proportion of patients discharged home to live independently. The benefits of SCU reported in larger tertiary centers extend to smaller community hospitals with more limited resources.
Source: Stroke - December 23, 2013 Category: Neurology Authors: Tamm, A., Siddiqui, M., Shuaib, A., Butcher, K., Jassal, R., Muratoglu, M., Buck, B. H. Tags: Health policy and outcome research, Acute Cerebral Hemorrhage, Acute Cerebral Infarction, Other Stroke Treatment - Medical Clinical Sciences Source Type: research

North American SOLITAIRE Stent-Retriever Acute Stroke Registry: Choice of Anesthesia and Outcomes Clinical Sciences
Conclusions— The NASA Registry has demonstrated that clinical outcomes and survival are significantly better in patients treated with LA, without increased symptomatic intracranial hemorrhage risk. Future trials should prospectively evaluate the effect of GA on outcomes.
Source: Stroke - April 28, 2014 Category: Neurology Authors: Abou-Chebl, A., Zaidat, O. O., Castonguay, A. C., Gupta, R., Sun, C.-H. J., Martin, C. O., Holloway, W. E., Mueller-Kronast, N., English, J. D., Linfante, I., Dabus, G., Malisch, T. W., Marden, F. A., Bozorgchami, H., Xavier, A., Rai, A. T., Froehler, M. Tags: Acute Cerebral Infarction, Emergency treatment of Stroke, Other Stroke Treatment - Surgical Clinical Sciences Source Type: research

Safety of Thrombolysis in Patients With Acute Ischemic Stroke and Cerebral Cavernous Malformations Brief Reports
Conclusions— Given the limitations of our study (mainly low number of patients with CCM), the risk of thrombolysis-associated hemorrhage in patients with CCM remains uncertain. Although our data do not suggest an increased hazard from thrombolysis in patients with CCM, larger studies are necessary to determine definitively the influence of CCMs on parenchymal hemorrhage and symptomatic intracerebral hemorrhage.
Source: Stroke - May 27, 2014 Category: Neurology Authors: Erdur, H., Scheitz, J. F., Tutuncu, S., Fiebach, J. B., Endres, M., Werring, D. J., Nolte, C. H. Tags: Acute Cerebral Infarction, Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage, Emergency treatment of Stroke, Intracerebral Hemorrhage, Thrombolysis Brief Reports Source Type: research

Race/Ethnic Differences in the Risk of Hemorrhagic Complications Among Patients With Ischemic Stroke Receiving Thrombolytic Therapy Clinical Sciences
Conclusions— In patients with stroke receiving tPA, hemorrhagic complications were slightly higher in blacks and Asians, but not in Hispanics compared with whites. Asians also faced significantly higher risk for sICH relative to other race/ethnic groups. Future studies are needed to evaluate whether reduction in tPA dose similar to that used in many Asian countries could improve the safety of tPA therapy in Asians in the United States with acute ischemic strokes while maintaining efficacy.
Source: Stroke - July 28, 2014 Category: Neurology Authors: Mehta, R. H., Cox, M., Smith, E. E., Xian, Y., Bhatt, D. L., Fonarow, G. C., Peterson, E. D., for the Get With The Guidelines-Stroke Program Tags: Thrombolysis Clinical Sciences Source Type: research

Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Stroke Is Better Than Low Doses Clinical Sciences
Conclusions— Our study suggests that standard-dose intravenous tPA for stroke had more favorable outcome without increasing the risk of symptomatic intracranial hemorrhage than low-dose tPA. For Asian people, 0.9 mg/kg should be the optimal dose of tPA to treat acute ischemic stroke.
Source: Stroke - July 28, 2014 Category: Neurology Authors: Liao, X., Wang, Y., Pan, Y., Wang, C., Zhao, X., Wang, D. Z., Wang, C., Liu, L., Wang, Y., on behalf of the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China Investigators Tags: Acute Cerebral Infarction, Thrombolysis Clinical Sciences Source Type: research

Optimizating Clot Retrieval in Acute Stroke: The Push and Fluff Technique for Closed-Cell Stentrievers Clinical Sciences
Conclusions— The PFT is safe and leads to optimization of wall apposition and cell size/configuration, resulting in higher chances of first-pass reperfusion, lower number of passes, and better rates of complete reperfusion.
Source: Stroke - September 28, 2015 Category: Neurology Authors: Haussen, D. C., Rebello, L. C., Nogueira, R. G. Tags: Emergency treatment of Stroke, Other imaging, Other Stroke Treatment - Surgical Clinical Sciences Source Type: research

Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Observational Studies Clinical Sciences
Conclusions— Overall, the use of NSAIDs is not associated with an increased risk of hemorrhagic stroke, although this risk was modestly significantly elevated in diclofenac and meloxicam users.
Source: Stroke - January 25, 2016 Category: Neurology Authors: Ungprasert, P., Matteson, E. L., Thongprayoon, C. Tags: Risk Factors, Cerebrovascular Disease/Stroke, Intracranial Hemorrhage Clinical Sciences Source Type: research

Streamlined Hyperacute Magnetic Resonance Imaging Protocol Identifies Tissue-Type Plasminogen Activator-Eligible Stroke Patients When Clinical Impression Is Stroke Mimic Clinical Sciences
Conclusions— A streamlined hMRI protocol permitted tPA administration to a small, but significant, subset of AIS patients initially considered to have SM.
Source: Stroke - March 27, 2016 Category: Neurology Authors: Goyal, M. S., Hoff, B. G., Williams, J., Khoury, N., Wiesehan, R., Heitsch, L., Panagos, P., Vo, K. D., Benzinger, T., Derdeyn, C. P., Lee, J.-M., Ford, A. L. Tags: Magnetic Resonance Imaging (MRI), Cerebrovascular Disease/Stroke, Ischemic Stroke Clinical Sciences Source Type: research

Direct Mechanical Intervention Versus Combined Intravenous and Mechanical Intervention in Large Artery Anterior Circulation Stroke: A Matched-Pairs Analysis Clinical Sciences
Conclusions— In patients with large anterior circulation stroke, direct mechanical intervention seems to be equally effective as bridging thrombolysis. A randomized trial comparing direct MT with bridging therapy is warranted.
Source: Stroke - March 27, 2016 Category: Neurology Authors: Broeg-Morvay, A., Mordasini, P., Bernasconi, C., Buhlmann, M., Pult, F., Arnold, M., Schroth, G., Jung, S., Mattle, H. P., Gralla, J., Fischer, U. Tags: Cardiopulmonary Resuscitation and Emergency Cardiac Care, Treatment, Ischemic Stroke Clinical Sciences Source Type: research

ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2 Clinical Sciences
Conclusions— Treatment with intravenous albumin 25% at 2 g/kg was not associated with improved outcome at 90 days and was associated with increased rates of intracerebral hemorrhage and pulmonary edema. Clinical Trial Registration— URL: https://www.clinicaltrials.gov. Unique identifier: NCT00235495.
Source: Stroke - August 21, 2016 Category: Neurology Authors: Martin, R. H., Yeatts, S. D., Hill, M. D., Moy, C. S., Ginsberg, M. D., Palesch, Y. Y., for the ALIAS Parts 1 and 2 and NETT Investigators Tags: Clinical Studies, Ischemic Stroke Clinical Sciences Source Type: research

Influence of Device Choice on the Effect of Intra-Arterial Treatment for Acute Ischemic Stroke in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) Clinical Sciences
Conclusions— We found no evidence for a differential effect of thrombectomy for acute ischemic stroke by type of stent. Clinical Trial Registration— URL: http://www.isrctn.com. Unique identifier: ISRCTN10888758.
Source: Stroke - September 25, 2016 Category: Neurology Authors: Dippel, D. W., Majoie, C. B., Roos, Y. B., van der Lugt, A., van Oostenbrugge, R. J., van Zwam, W. H., Lingsma, H. F., Koudstaal, P. J., Treurniet, K. M., van den Berg, L. A., Beumer, D., Fransen, P. S., Berkhemer, O. A., for the MR CLEAN Investigators Tags: Ischemic Stroke Clinical Sciences Source Type: research

Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients Brief Reports
Conclusions— Intravenous tirofiban immediately after alteplase seems to be safe and potentially more effective when compared with alteplase alone for selected stroke patients. Clinical Trial Registration— URL: http://www.chictr.org.cn/. Unique identifier: ChiCTR-TRC-14004630.
Source: Stroke - September 25, 2016 Category: Neurology Authors: Li, W., Lin, L., Zhang, M., Wu, Y., Liu, C., Li, X., Huang, S., Liang, C., Wang, Y., Chen, J., Feng, W. Tags: Pharmacology, Treatment, Ischemic Stroke Brief Reports Source Type: research